Infosys added 2.44% to Rs 1,802.15 after the company increased its FY25 revenue guidance to 3% – 4%.
Posts in category Business Standard
SpiceJet gains 5% on fresh capital raising plan; stock up 12% in 4 days (19-07-2024)
However, in the past six months, the SpiceJet stock has underperformed the market by falling nearly 10 per cent, as compared to 13 per cent rally in the BSE Sensex.
Information Technology shares rise (19-07-2024)
Information Technology stocks were trading with gains, with the BSE Information Technology index rising 248.44 points or 0.61% at 40956.21 at 09:45 IST.
FMCG stocks edge higher (19-07-2024)
FMCG stocks were trading in green, with the BSE Fast Moving Consumer Goods index increasing 26.53 points or 0.12% at 22159.03 at 09:45 IST.
Dr. Reddy’s inks patent licensing agreement with Takeda to commercialise Vonoprazan in India (19-07-2024)
Dr. Reddy’s Laboratories said that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to commercialise Vonoprazan tablets in India.
Zydus Life Vadodara unit gets OAI report from USFDA (19-07-2024)
The US drug regulator conducted an inspection between 15 April 2024 and 23 April 2024.
Dr. Reddy’s inks patent licensing agreement with Takeda (19-07-2024)
To commercialise Vonoprazan tablets in India
HUL Q1 preview: FMCG major may see volume-led growth in June quarter (19-07-2024)
Earlier this week, Hindustan Unilever approved the sale of its water purification business to AO Smith India for an Enterprise Value (EV) of Rs 601 crore or $72 million.
Barometers drift lower; Nifty below 24,800; breadth negative (19-07-2024)
At 09:30 IST, the barometer index, the S&P BSE Sensex, was down 79.64 points or 0.10% to 81,263.82. The Nifty 50 index shed 32.15 points or 0.13% to 24,768.70.
Infosys stock best IT bet post Q1, say analysts; target price increased (19-07-2024)
This came after Infosys trumped street estimates in its financial performance for the first quarter of financial year 2024-25 (Q1FY25) while also giving higher growth guidance than expected for FY25